tiprankstipranks
Telesis Bio (TBIO)
OTHER OTC:TBIO
US Market

Telesis Bio (TBIO) Income Statement

Compare
138 Followers

Telesis Bio Income Statement

Last quarter (Q3 2024), Telesis Bio's total revenue was $1.57M, a decrease of -71.85% from the same quarter last year. In Q3, Telesis Bio's net income was $-6.64M. See Telesis Bio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 27.51M$ 27.43M$ 11.04M$ 6.58M$ 4.80M
Gross Profit
$ 16.95M$ 15.60M$ 4.30M$ 3.63M$ -4.08M
Operating Expenses
$ 63.49M$ 62.08M$ 39.67M$ 19.99M$ 2.89M
Depreciation and Amortization
$ 4.10M$ 2.88M$ 1.57M$ 1.46M$ 857.00K
EBITDA
$ -40.49M$ -43.62M$ -36.00M$ -15.49M$ -6.12M
Operating Income
$ -46.54M$ -46.48M$ -35.37M$ -16.36M$ -6.98M
Other Income/Expenses
$ -1.16M$ -1.96M$ -3.57M$ -1.64M$ -1.33M
Pretax Income
$ -47.70M$ -48.45M$ -38.94M$ -18.00M$ -8.30M
Net Income
$ -47.72M$ -48.47M$ -38.96M$ -18.01M$ -8.30M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.64$ -1.65$ -1.33$ -0.62$ -0.20
Diluted EPS
$ -29.56$ -1.65$ -1.33$ -0.62$ -0.20
Weighted Average Shares Outstanding
29.85M 29.46M 29.32M 29.23M 40.76M
Weighted Average Shares Outstanding (Diluted)
1.66M 29.46M 29.32M 29.23M 40.76M
Currency in USD

Telesis Bio Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis